주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
295 )
기사목록 보기 형태
제목형
요약형
포토형
Few beds left for severely ill Covid-19 patients in greater Seoul
Han Soo Lee
2021.11.25 18:01
Daiichi Sankyo’s triple combo drug shows promising real-world clinical data
Shim Hyun-tai
2021.11.24 18:11
Celltrion to supply Covid-19 treatment Regkirona to more medical facilities
Shim Hyun-tai
2021.11.24 17:06
Korea may suspend ‘living with Covid’ scheme if virus spread aggravates
Shim Hyun-tai
2021.11.23 18:39
Alcon holds online workshop to share retinal surgery know-how
Shim Hyun-tai
2021.11.23 17:16
SNU team finds world’s 1st medication treatment for rotator cuff disease
Shim Hyun-tai
2021.11.23 15:29
SNUH to help build 1st university hospital in Laos
Shim Hyun-tai
2021.11.22 12:37
Genexine expects GX-19N to prevent Covid-19 for decades
Shim Hyun-tai
2021.11.19 20:57
Korea enters into integrated operation of national hospital beds
Shim Hyun-tai
2021.11.19 19:18
Weekly 5-level risk rating will decide whether to keep going back to normal
Shim Hyun-tai
2021.11.17 19:18
BioLeaders one step closer to homegrown oral Covid-19 treatment
Shim Hyun-tai
2021.11.17 17:03
Yuhan gets $9.97 million milestone payment from Boehringer Ingelheim for NASH therapy
Shim Hyun-tai
2021.11.17 14:08
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기